Drugs

Rituximab Approval Information - Licensing Action

Proper name: Rituximab
Tradename: Rituxan
Manufacturer: IDEC Pharmaceutical Corp, San Diego, CA, License #1235
Indication for Use: Revise the dosage and administration section of the package insert to include information regarding the use of Rituximab as a component of the Zevalin therapeutic regimen
Approval Date: 2/19/2002
Type of submission: Biologics license application supplement

 


Label (Part 2)

Page Last Updated: 04/06/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English